BRISTOL-MYERS SQUIBB — Ethics & Boards

Corporation with Board of Directors
United States
Closing date: December 31
Date of the Last Annual General Meeting: May 3, 2022
- S&P 100
- E&B Pharmaceuticals & Biotechnology

Governance leadership structure

Board of Directors

Giovanni CAFORIO
Chair
Since almost 6 years

Other directorships

11 voting members without any non-voting

Independents
Executives
Employees representatives
State representatives
Other

Directors
average seniority 4.9 years
4.9 years for elected by shareholders

Directors
average age 61.5 years
61.6 years for elected by shareholders

Chair and CEO roles are combined:
Is there a Lead Independent Director?	Yes
Are all of the Audit Committee members independent?	Yes
Majority of independent members in the Board?	Yes

15 members

Executive Committee

Giovanni CAFORIO
Chief Executive Officer
Since almost 8 years
Other directorships

Board & Leadership

Board of Directors

Your Internet Explorer version is outdated. Upgrade it, or download Google Chrome for a better experience.